Top member reports
Consensus community valuation
Contributing Members
Sort by:
#ASX Announcements
Added 12 months ago

Immuron Reports Neutralizing activity Against SARS-CoV-2

Key Points

* Immuron’s IMM-124E used to manufacture Travelan® and Protectyn® demonstrates antiviral activity against the COVID-19 virus in laboratory studies

* Immuron’s technology platform offers a potential new oral therapeutic approach to target SARS-CoV-2 in the GI Tract

View Attachment

Read More